D
DMAC
Diamedica Therapeutics Inc
8.01
+0.02+0.25%After Hours: 8.01 0.00 0.00%17:12 10/08 EDT
OPEN/PREV CLOSE7.92/7.99
TODAY RANGE7.66-8.06
VOL240.27K
MARKET CAP431.94M
52 WEEK RANGE5.25-10.42
AVG VOL (3M)177.44K
% TURNOVER0.38%
TURNOVER--
P/E (TTM)-11.1997
% RANGE5.01%
EPS(TTM)-0.7152
P/E(FORWARD)-9.8585
P/B11.27
BVPS0.7109
DIVIDEND--
P/S25.70
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP244.60M
SHARES OUTSTANDING53.93M
NEXT EARNINGS11/10-11/16
FREE FLOAT30.54M
LOT SIZE1
EX-DATE11/15/2018
News
Press Releases
Financial Reports
Profile
TipRanks·09/22 09:45
H.C. Wainwright Keeps Their Buy Rating on Diamedica Therapeutics (DMAC)
TipRanks·08/24 00:08
Diamedica Therapeutics Balances Trial Momentum and Cash
TipRanks·08/11 15:11
DiaMedica Expands Equity Incentive Pool With New S-8 Share Registration
TipRanks·08/10 22:51
DiaMedica Advances Key Phase 2 Programs and Extends Cash Runway Through 2027
Seeking Alpha·08/10 20:54
DiaMedica Therapeutics GAAP EPS of -$0.19 beats by $0.01
Dow Jones·08/10 20:30
*Diamedica Therapeutics 2Q Loss/Shr 19c >DMAC
Benzinga·06/29 12:11
Biohaven, Goodyear Tire And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
TipRanks·06/25 11:50
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks·06/23 17:08
DiaMedica Therapeutics announces dosing of first two patients in DM199 study
TipRanks·06/18 09:47
Craig-Hallum Remains a Buy on Diamedica Therapeutics (DMAC)
TipRanks·06/16 12:37
DiaMedica Therapeutics receives written response from FDA on DM199
Same Industry
Name/Symbol
Change%
Price